| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/06/2007 | CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/06/2007 | CN1974587A Basic hydrolysis process for preparing 2-fluoro [18F]-2-deoxy-beta-D-glucose in single tube FDG acidic hydrolysis apparatus |
| 06/06/2007 | CN1319599C RI labelled composition synthesis system |
| 06/05/2007 | US7226577 Gastrin releasing peptide compounds |
| 05/31/2007 | WO2007060012A2 Use of l-phenylalanine conjugated to an emitting isotope for therapy of hormone dependent carcinoma |
| 05/31/2007 | WO2007059782A1 Recombinant monovalent antibodies and methods for production thereof |
| 05/31/2007 | WO2007015094A3 Use of peptides for imaging blood clots |
| 05/31/2007 | WO2007011680A3 Ligands to radiation-induced molecules |
| 05/31/2007 | WO2007001958A3 Stereoselective synthesis of amino acid analogs for tumor imaging |
| 05/31/2007 | WO2006102163A3 Transfection reagents for non-adherent suspension cells |
| 05/31/2007 | WO2006074272A3 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070122343 Non-invasive assay for the assessment of functioning and/or structure of the gut |
| 05/31/2007 | US20070122342 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) dicarboxylic acid-targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand |
| 05/31/2007 | US20070122341 Benzylideneaniline derivatives and their radioisotope labeled compounds for binding and imaging of beta-amyloid plaques |
| 05/31/2007 | US20070122340 Necrosis avid tracer agent |
| 05/31/2007 | CA2631184A1 Recombinant monovalent antibodies and methods for production thereof |
| 05/31/2007 | CA2630600A1 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790662A1 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 05/30/2007 | EP1789098A2 Radiolabelled insulin |
| 05/30/2007 | EP1091742A4 Indium photosensitizers for pdt |
| 05/30/2007 | CN1972720A Alpha-emitting hydroxyapatite particles |
| 05/30/2007 | CN1972719A Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 05/30/2007 | CN1972718A Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 05/30/2007 | CN1970087A Organic metal carborane target formulation and its preparation method |
| 05/30/2007 | CN1318481C Biodegradable fluorescent polyphosphonitrile and process for synthesis thereof |
| 05/30/2007 | CN1318095C Tracer agent for oxygen lacking tumor cell and its usage |
| 05/29/2007 | US7223542 Diagnosing cancer via determining concentration of marker polypeptides; genetic vaccines; antiproliferative/antitumor agents |
| 05/29/2007 | US7223380 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) dicarboxylic acid-targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand |
| 05/29/2007 | CA2154867C Gas mixtures useful as ultrasound contrast media |
| 05/24/2007 | WO2007059082A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/24/2007 | WO2007057909A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies |
| 05/24/2007 | WO2007057705A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |
| 05/24/2007 | WO2007032005A3 Novel amine-borane compounds and uses thereof |
| 05/24/2007 | WO2007026140A3 Use of a labelled marker for determinating the kidney function |
| 05/24/2007 | WO2007013060A3 A radioactive surface source and a method for producing the same |
| 05/24/2007 | US20070116644 Detectable labeled cobalamin (adenosylcolbalamin) conjugated with peptidesor amino acid residues linked to a chelate compound (ETDA) including a metal radionuclide;antitumor, anticarcinogenic agents; contrast agent for imaging; diagnosis; nontoxic;bioavailability; detectable at low concentrations |
| 05/24/2007 | CA2629453A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/23/2007 | EP1787624A1 Skin-lightening agent containing polyphenol compound |
| 05/23/2007 | EP1786464A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 05/23/2007 | EP1417183B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/23/2007 | EP1140203B1 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2007 | CN1969190A Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 05/23/2007 | CN1968705A Carboranylporphyrins and uses thereof |
| 05/23/2007 | CN1966140A Chemical synthesizer capable of preparing multiple fluoro-marking agent |
| 05/22/2007 | US7220827 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 05/22/2007 | US7220730 Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer |
| 05/22/2007 | US7220401 To deliver a radionuclide to a blood clot, to obtain an ultrasound image of a blood clot, for diagnosis, therapy |
| 05/22/2007 | US7220400 Delivering a biopolymer to a cell by forming a complex of a biologically active polymer and a cyclic amidinium-containing compound and associating the complex with the cell. |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | US7220272 Composite staple and method for using same |
| 05/18/2007 | WO2007056440A1 Treatment and prevention of adverse liver conditions using gallium |
| 05/18/2007 | WO2007054940A2 Breath test device and method |
| 05/18/2007 | WO2007054938A2 Optics for an extended depth of field |
| 05/18/2007 | WO2007003944A3 Compounds for imaging and therapy |
| 05/18/2007 | CA2637782A1 Treatment and prevention of adverse liver conditions using gallium |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070110748 Fibronectin binding protein compositions and methods of use |
| 05/17/2007 | US20070110668 Modulation of Immunity and Ceacam1 Activity |
| 05/17/2007 | US20070110667 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 05/17/2007 | US20070110666 Methods for preparation of live body tissues for examination |
| 05/17/2007 | US20070110665 Tissue marker for multimodality radiographic imaging |
| 05/17/2007 | US20070110664 Method and apparatus for synthesis of [11c] phosgen using concentrated [11c] carbon monoxide with uv light |
| 05/16/2007 | EP1588145A4 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | CN1965082A 人源化抗体 Humanized antibodies |
| 05/16/2007 | CN1964712A Selective androgen receptor modulators and methods of use thereof |
| 05/16/2007 | CN1962659A 2- fluoro -N,N- dimethyl -2-(6-methyl-2-p-tolylimidazole [1,2-a] pyridine)-3- acetamide compound and its preparation method |
| 05/16/2007 | CN1315452C Pharmaceutical dosage form and method of making |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217410 Forming image of sample and coated microparticle mixture by exposing to electromagnetic radiation of infrared or ultraviolet frequency; optical coherence tomography, holography, endoscopy; light, confocal, polarization, interference, and/ormulti-photon microscopy |
| 05/15/2007 | US7217409 Suspension stabilizing agents for pharmaceutical aerosols |
| 05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/10/2007 | WO2007053718A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/10/2007 | WO2007052274A2 Magnetic resonance imaging and spectroscopy means and methods thereof |
| 05/10/2007 | WO2007052267A2 Biodegradable composite for internal local radiotherapy |
| 05/10/2007 | WO2007051773A1 Method of scintigraphy |
| 05/10/2007 | WO2007025282A9 Use of fructose-based compounds for the diagnosis of cancer |
| 05/10/2007 | WO2007000283A3 A preparation, kit and apparatus for the diagnosis of female utero-tubal perviousness and function |
| 05/10/2007 | WO2006102395A3 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/10/2007 | WO2006052691A3 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 05/10/2007 | US20070105888 Metabolically resistant 41-[13C]methoxyl rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (41-[13C]methoxyl CCI-779); study pharmacokinetics; Rapamycin 31-O-trimethyl silyl ether, 42-ester with 2,2,5-trimethyl[1,3-dioxane]-5-carboxylic acid; treat cancers |
| 05/10/2007 | US20070104658 Preparing spray-dried particles having a tap density of less than about 0.4 g/cm3 and have a hydrophobic amino acid and a therapeutic, prophylactic or diagnostic agent; pulmonary delivery; respiratory disorders |
| 05/10/2007 | US20070104647 Ovr115 antibody compositions and methods of use |
| 05/10/2007 | US20070104646 Stabilized and lyophilized radiopharmaceutical agents |
| 05/10/2007 | US20070104645 Chelate based scaffolds in tumor targeting |
| 05/10/2007 | US20070104644 Inhibitor imaging agents |
| 05/10/2007 | CA2628608A1 Magnetic resonance imaging and spectroscopy means and methods thereof |
| 05/10/2007 | CA2627890A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1781339A1 Compounds of the inventions of guanylyl cyclase c |
| 05/09/2007 | CN1960756A Cytotoxicity mediation of cells evidencing cell membrane surface expression of CD63 |
| 05/09/2007 | CN1960755A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 05/09/2007 | CN1960707A Liposomal assembly for therapeutic and/or diagnostic use |
| 05/09/2007 | CN1958615A Antibody of anti human CD20 from human resources functionally, and application |
| 05/09/2007 | CN1314456C Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane |
| 05/03/2007 | WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |